Our intrathecal treatment are exclusive to those not on blood thinners. Best for: Brain Optimization Early-Onset Dementia can significantly impact memory, cognitive function, and daily life at a younger age than typical dementia cases. At Decima, our MSC (Mesenchymal Stem Cell) therapy provides a supportive option for individuals seeking innovative approaches to enhance overall brain health. This treatment involves the intrathecal administration of MSCs, which are known for their potential to target inflammation and support neural function. While not a cure, this therapy is designed to complement current care strategies by promoting cellular balance and addressing the factors contributing to cognitive decline. Decima Stem Cells is committed to help people navigate complex neurological conditions like Early-Onset Dementia.